Does MIRTAZAPINE Cause Malignant neoplasm progression? 36 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Malignant neoplasm progression have been filed in association with MIRTAZAPINE (Mirtazapine). This represents 0.1% of all adverse event reports for MIRTAZAPINE.
36
Reports of Malignant neoplasm progression with MIRTAZAPINE
0.1%
of all MIRTAZAPINE reports
9
Deaths
15
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MIRTAZAPINE?
Of the 36 reports, 9 (25.0%) resulted in death, 15 (41.7%) required hospitalization, and 2 (5.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRTAZAPINE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does MIRTAZAPINE Cause?
Toxicity to various agents (2,758)
Drug ineffective (1,874)
Somnolence (1,695)
Completed suicide (1,535)
Fall (1,461)
Intentional overdose (1,458)
Drug abuse (1,408)
Dizziness (1,234)
Fatigue (1,192)
Nausea (1,142)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MIRTAZAPINE Alternatives Have Lower Malignant neoplasm progression Risk?
MIRTAZAPINE vs MIRVASO
MIRTAZAPINE vs MIRVETUXIMAB SORAVTANSINE-GYNX
MIRTAZAPINE vs MISOPROSTOL
MIRTAZAPINE vs MITAPIVAT
MIRTAZAPINE vs MITOMYCIN